https://www.aidsmap.com/news/dec-2015/grazoprevirelbasvir-cures-more-90-people-hivhcv-co-infection
Grazoprevir/elbasvir cures more than 90% of people with HIV/HCV co-infection | aidsmap
Merck's grazoprevir/elbasvir combination cured 93% of people with HIV and hepatitis C co-infection, was well-tolerated and did not appear to interact with...
hiv hcv co infection